Savo Bou Zein Eddine, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Penetrating | 2 | 2019 | 316 | 1.080 |
Why?
|
| Thoracic Injuries | 2 | 2019 | 288 | 1.060 |
Why?
|
| Pneumothorax | 2 | 2019 | 392 | 1.000 |
Why?
|
| Appendectomy | 3 | 2019 | 444 | 0.830 |
Why?
|
| Appendicitis | 3 | 2019 | 679 | 0.830 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2019 | 806 | 0.790 |
Why?
|
| Thoracostomy | 1 | 2019 | 78 | 0.610 |
Why?
|
| Abdominal Abscess | 1 | 2019 | 152 | 0.600 |
Why?
|
| Carotid Artery Injuries | 1 | 2018 | 96 | 0.590 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2019 | 644 | 0.570 |
Why?
|
| Observation | 1 | 2019 | 309 | 0.560 |
Why?
|
| Surgical Wound Infection | 2 | 2019 | 1543 | 0.430 |
Why?
|
| Anti-Bacterial Agents | 4 | 2019 | 7477 | 0.410 |
Why?
|
| Wound Closure Techniques | 1 | 2020 | 88 | 0.330 |
Why?
|
| Prognathism | 1 | 2019 | 26 | 0.330 |
Why?
|
| Malocclusion, Angle Class III | 1 | 2019 | 38 | 0.320 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 2081 | 0.310 |
Why?
|
| Bandages | 1 | 2020 | 269 | 0.310 |
Why?
|
| Sutures | 1 | 2020 | 283 | 0.310 |
Why?
|
| Tracheostomy | 1 | 2020 | 429 | 0.270 |
Why?
|
| Subacute Care | 1 | 2023 | 184 | 0.180 |
Why?
|
| Metal Nanoparticles | 1 | 2015 | 403 | 0.170 |
Why?
|
| Mandibular Injuries | 1 | 2019 | 20 | 0.170 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2740 | 0.170 |
Why?
|
| Guideline Adherence | 1 | 2019 | 2242 | 0.160 |
Why?
|
| Hypothermia | 1 | 2020 | 190 | 0.160 |
Why?
|
| Mandibular Fractures | 1 | 2019 | 77 | 0.160 |
Why?
|
| Molecular Imaging | 1 | 2015 | 822 | 0.160 |
Why?
|
| Cerebrovascular Trauma | 1 | 2018 | 21 | 0.150 |
Why?
|
| Vascular System Injuries | 1 | 2022 | 246 | 0.150 |
Why?
|
| Injury Severity Score | 2 | 2019 | 1049 | 0.150 |
Why?
|
| Antibodies | 1 | 2015 | 2416 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 2185 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20667 | 0.140 |
Why?
|
| Fracture Fixation | 1 | 2019 | 369 | 0.140 |
Why?
|
| Ectodermal Dysplasia | 1 | 2017 | 106 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1929 | 0.130 |
Why?
|
| Stroke | 1 | 2018 | 9747 | 0.130 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 4850 | 0.120 |
Why?
|
| Lebanon | 2 | 2019 | 246 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2022 | 1387 | 0.110 |
Why?
|
| Trauma Centers | 1 | 2019 | 950 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2019 | 1470 | 0.110 |
Why?
|
| Conflict of Interest | 1 | 2017 | 556 | 0.100 |
Why?
|
| Length of Stay | 2 | 2019 | 6487 | 0.090 |
Why?
|
| Patient Readmission | 2 | 2019 | 3286 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2020 | 15749 | 0.090 |
Why?
|
| Adult | 11 | 2023 | 222974 | 0.090 |
Why?
|
| Drug Industry | 1 | 2017 | 791 | 0.090 |
Why?
|
| Reoperation | 1 | 2019 | 4294 | 0.080 |
Why?
|
| Syria | 1 | 2019 | 88 | 0.080 |
Why?
|
| Time Factors | 3 | 2019 | 40066 | 0.080 |
Why?
|
| Middle Aged | 9 | 2022 | 222903 | 0.080 |
Why?
|
| Appendix | 1 | 2019 | 109 | 0.080 |
Why?
|
| Aged | 8 | 2023 | 171050 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 1945 | 0.080 |
Why?
|
| Young Adult | 6 | 2020 | 59852 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 1659 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 5442 | 0.070 |
Why?
|
| Intestinal Perforation | 1 | 2019 | 253 | 0.070 |
Why?
|
| Cephalometry | 1 | 2019 | 380 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 18061 | 0.070 |
Why?
|
| Female | 13 | 2023 | 395961 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2019 | 640 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2023 | 81457 | 0.060 |
Why?
|
| Male | 10 | 2023 | 363585 | 0.060 |
Why?
|
| Humans | 16 | 2023 | 765734 | 0.060 |
Why?
|
| Medicare | 1 | 2023 | 6821 | 0.060 |
Why?
|
| Zinc Oxide | 1 | 2015 | 25 | 0.060 |
Why?
|
| Copper Radioisotopes | 1 | 2015 | 99 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 59459 | 0.060 |
Why?
|
| Nanocapsules | 1 | 2015 | 92 | 0.060 |
Why?
|
| Drainage | 1 | 2019 | 1180 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 4057 | 0.050 |
Why?
|
| Pedigree | 1 | 2019 | 4524 | 0.050 |
Why?
|
| Rewarming | 1 | 2020 | 63 | 0.040 |
Why?
|
| Gestational Age | 1 | 2019 | 3612 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 1145 | 0.040 |
Why?
|
| Minnesota | 1 | 2020 | 336 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7875 | 0.040 |
Why?
|
| Popliteal Artery | 1 | 2022 | 301 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2022 | 65180 | 0.040 |
Why?
|
| Physicians | 1 | 2017 | 4587 | 0.040 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 6546 | 0.040 |
Why?
|
| Adolescent | 3 | 2020 | 88781 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2022 | 22224 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4772 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39180 | 0.040 |
Why?
|
| Costello Syndrome | 1 | 2017 | 19 | 0.040 |
Why?
|
| SOS1 Protein | 1 | 2017 | 40 | 0.040 |
Why?
|
| Catheters | 1 | 2020 | 426 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2626 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 21053 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2017 | 138 | 0.030 |
Why?
|
| Facies | 1 | 2017 | 223 | 0.030 |
Why?
|
| Noonan Syndrome | 1 | 2017 | 122 | 0.030 |
Why?
|
| Gift Giving | 1 | 2017 | 76 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2019 | 5986 | 0.030 |
Why?
|
| Genome, Human | 1 | 2019 | 4446 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6219 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 42468 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 54795 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2015 | 2699 | 0.030 |
Why?
|
| Mandible | 1 | 2019 | 746 | 0.030 |
Why?
|
| Social Class | 1 | 2023 | 2007 | 0.030 |
Why?
|
| Child | 2 | 2018 | 80499 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 2022 | 1485 | 0.030 |
Why?
|
| Public Opinion | 1 | 2017 | 482 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 30184 | 0.030 |
Why?
|
| Trust | 1 | 2017 | 532 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2023 | 1945 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15883 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 36537 | 0.020 |
Why?
|
| Medicaid | 1 | 2023 | 2833 | 0.020 |
Why?
|
| Boston | 1 | 2022 | 9337 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 17062 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 9245 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 30248 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 2794 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 74831 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8293 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7424 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10846 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 4698 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 41631 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2017 | 12123 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 81792 | 0.010 |
Why?
|
| United States | 1 | 2023 | 72898 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 168731 | 0.010 |
Why?
|